[1] ANDERSON B O,JAKESZ R. Breast cancer issues in developing countries:an overview of the breast health global initiative[J]. World J Surg,2008,32(12):2578-2585.[2] SHARIFIAN A,POURHOSEINGHOLI M A,EMADEDIN M,et al. Burden of breast cancer in Iranian women is increasing[J]. Asian Pac J Cancer Prev,2015,16(12):5049-5052.[3] BEDOGNETTI D,MACCALLI C,BADER S B,et al. Checkpoint inhibitors and their application in breast cancer[J]. Breast Care,2016,11(2):108-115.[4] DOMSCHKE C,SCHNEEWEISS A,STEFANOVIC S,et al. Cellular immune responses and immune escape mechanisms in breast cancer:determinants of immunotherapy[J]. Breast Care, 2016,11(2):102-107.[5] 匡栩源,庄权,吴金泽,等.益生菌在肿瘤防治中的机制和应用[J].中国微生态学杂志,2011,23(3):274-276.[6] LóPEZ P,GONZáLEZ-RODRíGUEZ I,SáNCHEZ B,et al. Interaction of bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression[J]. Appl Environ Microbiol,2012,78(8):2850-2857.[7] SIVAN A,CORRALES L,HUBERT N,et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy[J]. Science,2015,350(6264):1084-1089.[8] 伊淑帅,王开,齐宇,等.干酪乳杆菌与氟苯尼考对肉雏鸡生长性能及免疫力影响的比较研究[J].中国兽药杂志,2015,49(9):31-36.[9] HAN D J,KIM J B,PARK S Y,et al. Growth inhibition of hepatocellular carcinoma huh7 cells by Lactobacillus casei extract[J]. Yonsei Med J,2013,54(5):1186-1193.[10] DALLAL M M S,MOJARRAD M,BAGHBANI F,et al. Effect of probiotic Lactobacillus acidophilus and Lactobacillus casei on colorectal tumor cells activity (CaCo-2)[J]. Arch Iran Med, 2015,18(3):167-172.[11] 董春景,梁惠,贺娟,等.海藻萜类化合物对二甲基苯蒽诱导的大鼠乳腺癌的抑制作用[J].营养学报,2007, 29(2):197-199.[12] TAVASSOLI F A,DEVILEE P. WHO:乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹,戴林,郭双平,等译.北京:人民卫生出版社,2006:1-118.[13] 托娅,杜瑞亭,张和平.益生菌Lb.casei Zhang对H22荷瘤小鼠的抗肿瘤作用及机制[J].肿瘤防治研究,2010, 37(4):463-465.[14] 吴英韬,解傲,袁杰利.多联益生菌对5-氟尿嘧啶诱发大鼠肠道菌群紊乱及肠黏膜损伤的保护作用[J].中国微生态学杂志,2016,28(4):378-382.[15] 胡帅尔,陈壁锋,李文立,等.益生菌对小鼠特异性及非特异性免疫功能的影响[J].公共卫生与预防医学,2010, 21(4):11-14.[16] HORINAKA M,YOSHIDA T,KISHI A,et al. Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells[J]. FEBS Lett,2010,584(3):577-582.[17] 周金黄,李晓玉,荣康泰.免疫药理学进展基础与临床[M].北京:科学出版社,1993:353-354.[18] 娄鸿飞,房居高,李平栋,等.CD4+CD25+Foxp3+调节性T细胞在鼻腔鼻窦鳞状细胞癌中的表达和免疫抑制功能研究[J]. 中国耳鼻咽喉头颈外科,2015,22(6):299-303.[19] 高祥,郭涛,黄婧,等.体外扩增的Treg细胞抑制NK细胞介导的抗肿瘤免疫[J].免疫学杂志,2015,31(4):308-312.[20] OGITA T,BERGAMO P,MAURANO F,et al. Modulatory activity of Lactobacillus rhamnosus OLL2838 in a mouse model of intestinal immunopathology[J]. Immunobiology,2015, 220(6):701-710.[21] MORTAZ E,ADCOCK I M,RICEIARDDO F L,et al. Anti-inflammatory effect of Lactobacillus rahmnosus and Bifidobacterium breve on cigarette smoke activated human macrophages[J]. PLoS One,2015,10(8):1-16.[22] HORMANNSPERGER G,VON SCHILLDE M A,HALLER D. Lactocepin as a protective microbial structure in the context of IBD[J]. Gut Microbes,2013,4(2):152-157.[23] HALLER D,BENGMARK S,ENCK P,et al. Guidance for substantiating the evidence for beneficial effects of probiotics:probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome[J]. J Nutr,2010, 140(3):690S-697.[24] ROCHE H,VIENS P,BIRON P,et al. High-dose chemotherapy for breast cancer:the french PEGASE experience[J]. Cancer Control,2003,10(1):42-47. |